Scientists summarize the current evidence indicating that aberrant or dysregulated N6‐methyladenosine (m6A) modification is associated with urological cancer development, progression and prognosis.
[Nature Reviews Urology]
Home Newsletters RNA N6-Methyladenosine Modifications in Urological Cancers: From Mechanism to Application
